Alert: New Earnings Report (2/27/24)-REGENXBIO Inc (NASDAQ: RGNX).
REGENXBIO Inc (NASDAQ: RGNX) has reported a loss for its fourth fiscal quarter (ending December 31) of $-1.43 versus a loss $-1.38 for the same period a year ago. This result fell short of the […]